Cinven buys second drug business Amdipharm
 

15-10-12 10:52 AM

LONDON (Reuters) - Private equity group Cinven is buying family-owned niche pharmaceuticals business Amdipharm for 367 million pounds ($590 million), it said on Monday, as part of a plan to create a much larger producer of generic drugs. Related Stories Geely executive says unaware of talks with UK taxi firm on cash injection Trinidad's Trinity Exploration to take over Bayfield Energy Bahrain's ...

Source...